Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex

Journal of Neurophysiology

Volumn 87, Issue 5, 2002, Pages 2324-2336

  Chen, Long ^a   Yang, Charles R ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMFEBUTAMONE; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; MALE; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SENSORY NERVE; SYNAPSE;

EID: 0036082508     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2002.87.5.2324     Document Type: Article

References (109)

1. The role of immediate early genes in the stabilization of long-term potentiation
2. Clozapine and haloperidol modulate N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro
3. 2A receptor antagonist and a potential antipsychotic drug facilitates N-methyl-D-aspartate receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro
4. 2A.2C receptor agonist DOB on NMD-evoked responses in the rat medial prefrontal cortex
5. Pharmacological actions of the atypical antipsychotic drug clozapine: A review
6. Blockade of NMDA receptors located at the dorsomedial prefrontal cortex impairs spatial working memory in rats
7. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses
8. Glutamale agonist activity: Implications for antipsychotic drug action and schizophrenia
9. Haloperidol and loxapine but not clozapine increase synaptic responses in the hippocampus
10. Criteria for distinguishing between monosynaptic and polysynaptic transmission
11. The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses
12. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: An in vivo microdialysis study
13. Cognitive deficit in schizophrenia and its neurochemical basis
14. Olanzapine: A basic science update
15. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum
16. Atypical antipsychotic clozapine augments NMDA receptor-mediated polysynaptic network transmission in prefrontal cortical neurons in vitro
17. Optimizing treatment with clozapine
18. Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats
19. Quantal components of the end-plate potential
20. Clozapine and seizures
21. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization
22. Seizures during clozapine therapy
23. NMDA AMPA receptors on neocortical neurons are differentially distributed
24. Recurrent excitation in neocortical circuits
25. A role for immediate-early transcription factors in learning and memory
26. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane
27. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits
28. Evoked extracellular dopamine in vivo in the medial prefrontal cortex
29. Dissociation of haloperidol, clozapine, and olanazapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex
30. Horizontal synaptic connections in monkey prefrontal cortex: An in vitro electrophysiological study
31. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
32. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
33. Clozapine improves dizocilpine-induced delayed alternation impairment in rats
34. Risperidone: Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain
35. Bidirectional, activity-dependent regulation of glutamate receptors in the adult hippocampus in vivo
36. D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus
37. Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus
38. Dendritic attenuation of synaptic potentials in the CA1 region of rat hippocampal slices detected with an optical method
39. Recent advances in the phencyclidine model of schizophrenia
40. A dendritic GABAA-mediated IPSP regulates facilitation of NMDA-mediated responses to burst stimulation of afferent fibres in piriform cortex
41. Tetrodotoxin-resistant electric activity in presynaptic terminals
42. + (GIRK) channels expressed in Xenopus oocytes
43. The molecular basis of dopamine and glutamate interactions in the striatum
44. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium
45. Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine
46. Paroxysmal EEG activity and psychopathology during the treatment with clozapine
47. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
48. Clozapine-induced potentiation of synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits
49. Effects of MK-801 on clozapine-induced potentiation of excitatory synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits
50. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
51. Intracellular modulation of NMDA receptor function by antipsychotic drugs
52. Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (area 9 and 46)
53. Control of NMDA receptor-mediated activity by GABAergic mechanisms in mature and developing rat neocortex
54. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine
55. A network of tufted layer 5 pyramidal neurons
56. Clozapine inhibits synaptic transmission at GABAergic synapses established by ventral tegmental area neurons in culture
57. Acute and chronic administration of clozapine produces greater proconvulsant actions than haloperidol on focal hippocampal seizures in freely moving rats
58. A molecular determinant for submillisecond desensitization in glutamate receptors
59. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys
60. MK-801 reverses Fos expression induced by the full dopamine D1 receptor agonist SKF-82958 in the rat striatum
61. Effects of olanzapine and other antipsychotic drugs on c-fos expression
62. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex
63. NMDA receptor hypofunction model of schizophrenia
64. Direct measurement of AMPA receptor desensitization induced by glutamatergic synaptic transmission
65. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen
66. N-methyl-D-aspartate antagonists and working memory performance: Comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyl-adenosine
67. D1 dopamine receptor-induced cAMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors
68. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex
69. 2+ channels are essential for glutamate-mediated CREB phosphrylation and c-fos gene expression in striatal neurons
70. Neuroleptics and dopamine transporters
71. Quantal analysis of synaptic potentials in neurons of the central nervous system
72. Blockade by antidepressants and related compounds of biogenic amin uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake
73. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
74. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum
75. The role of D1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task
76. NMDA spikes in basal dendrites of cortical pyramidal neurons
77. Direct evidence for biphasic cAMP responsive element-binding protein phosphorylation during long-term potentiation in the rat dentate gyrus in vivo
78. Dopamine D1/D5 receptor activation selectively enhances sustained synaptic inputs to layer V prefrontal cortex neurons
79. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat
80. 2+ potentials in the proximal versus distal dendrites to synaptic integration in prefrontal cortical neurons
81. Differential fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment
82. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: An in situ hybridization study
83. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter
84. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo
85. r 32 kDa)/protein phosphastase-1 pathway regulates dephosphorylation of the NMDA receptor
86. Postsynaptic protein phosphorylation and LTP
87. Clozapine and several other antipsychotic/antidepressant drugs preferentially block the same "core" fraction of GABA(A) receptors
88. Clozapine: The Yin and Yang of seizures and psychosis
89. Kindling with clozapine: Behavioral and molecular consequences
90. The neuronal network of the cerebral cortex: A functional interpretation
91. Schizophrenia and glutamatergic transmission
92. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
93. Synaptic interactions in neocortical local circuits: Dual intracellular recordings in vitro
94. Regulation of gene expression and its role in long-term memory and synaptic plasticity
95. Dopaminergic modulation of excitatory postysnaptic currents in rat neostriatal neurons
96. Immediate early gene transcription and synaptic modulation
97. D1 dopamine receptors potentiate nmda-mediated excitability increase in layer v prefrontal cortical pyramidal neurons
98. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex
99. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex
100. Thresholds for synaptic activation of transcription factors in hippocampus: Correlation with long-term enhancement
101. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations
102. Brain region effects of clozapine on amino acid and monoamine transmission
103. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin
104. Electrophysiological and morphological properties of layer V-VI principal pyramidal cells in rat prefrontal cortex in vitro
105. 2+
106. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus
107. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance
108. Opposite modulation of cortical N-methyl-D-aspartate receptor-mediated responses by low and high concentration of dopamine